These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 19747731)

  • 21. Cyclophosphamide/cyclosporin-A treatment of multicentric Castleman's disease with Kaposi's sarcoma.
    Bertero MT; De Maestri M; Caligaris-Cappio F
    Haematologica; 2000 Feb; 85(2):216-7. PubMed ID: 10681737
    [No Abstract]   [Full Text] [Related]  

  • 22. Near-total resolution of multicentric Castleman disease by prolonged treatment with thalidomide.
    Starkey CR; Joste NE; Lee FC
    Am J Hematol; 2006 Apr; 81(4):303-4. PubMed ID: 16550518
    [No Abstract]   [Full Text] [Related]  

  • 23. [Castleman disease complicated with paraneoplastic pemphigus--a case report].
    Pan DL; Li HZ; Mao QZ
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(4):273-5. PubMed ID: 15854492
    [No Abstract]   [Full Text] [Related]  

  • 24. Autoimmune pancreatitis in the setting of Castleman disease.
    Maithel SK; Pratt W; Kelleher T; Avigan D; Goldman H; Pfeifer W; Pihan GA; Vollmer CM
    Pancreas; 2007 Nov; 35(4):384-7. PubMed ID: 18090252
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of bortezomib on pro-inflammatory cytokine levels and transfusion dependency in a patient with multicentric Castleman disease.
    Hess G; Wagner V; Kreft A; Heussel CP; Huber C
    Br J Haematol; 2006 Sep; 134(5):544-5. PubMed ID: 16856889
    [No Abstract]   [Full Text] [Related]  

  • 26. Multicentric Castleman's disease complicated by secondary renal amyloidosis.
    Leung KT; Wong KM; Choi KS; Chau KF; Li CS
    Nephrology (Carlton); 2004 Dec; 9(6):392-3. PubMed ID: 15663642
    [No Abstract]   [Full Text] [Related]  

  • 27. [Chylothorax and chylous ascites as symptoms of Castleman's disease].
    Saaresranta T; Söderström KO; Ruokonen EL
    Duodecim; 1995; 111(4):348-50. PubMed ID: 8654303
    [No Abstract]   [Full Text] [Related]  

  • 28. Acute tumor lysis syndrome complicating fludarabine treatment of prolymphocytic leukemia.
    Cannon LM; Spilove L; Rhodes R; Garfinkel H; Pezzimenti J
    Conn Med; 1993 Oct; 57(10):651-4. PubMed ID: 8275684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyaline vascular Castleman disease associated with POEMS syndrome and cerebral infarction.
    Huang J; Wang L; Zhou W; Jin J
    Ann Hematol; 2007 Jan; 86(1):59-61. PubMed ID: 16953376
    [No Abstract]   [Full Text] [Related]  

  • 30. Renal involvement in multicentric Castleman disease with glomeruloid hemangioma of skin and plasmacytoma.
    Uthup S; Balachandran K; Ammal VA; Abdul Salam R; George J; Nair GM; Leela M
    Am J Kidney Dis; 2006 Aug; 48(2):e17-24. PubMed ID: 16860182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytopathologic findings in "POEMS" syndrome associated with Castleman disease.
    Owens CL; Weir EG; Ali SZ
    Diagn Cytopathol; 2007 Aug; 35(8):512-5. PubMed ID: 17636486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe hypoglycemia in a patient with acute renal failure due to tumor lysis syndrome.
    Shnaider A; Basok A; Rogachev B; Tovbin D; Mostoslavsky M
    Isr Med Assoc J; 2002 Sep; 4(9):730-1. PubMed ID: 12440245
    [No Abstract]   [Full Text] [Related]  

  • 33. Castleman disease: an update on classification and the spectrum of associated lesions.
    Cronin DM; Warnke RA
    Adv Anat Pathol; 2009 Jul; 16(4):236-46. PubMed ID: 19546611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial.
    Gérard L; Bérezné A; Galicier L; Meignin V; Obadia M; De Castro N; Jacomet C; Verdon R; Madelaine-Chambrin I; Boulanger E; Chevret S; Agbalika F; Oksenhendler E
    J Clin Oncol; 2007 Aug; 25(22):3350-6. PubMed ID: 17664482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical outcome of superficial and deep Castleman disease.
    Chen CH; Liu HC; Tung KY; Lee JJ; Liu CL; Liu TP
    ANZ J Surg; 2007 May; 77(5):339-43. PubMed ID: 17497971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diffuse large B-cell lymphoma arising from a multicentric mixed variant of Castleman's disease.
    Venizelos I; Tamiolakis D; Simopoulos C; Nikolaidou S; Barbagadaki S; Lambropoulou M; Alexiadis G; Boglou P; Papadopoulos N
    Indian J Cancer; 2004; 41(3):135-7. PubMed ID: 15472414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are multicentric Castleman's disease with cutaneous plasmacytosis and systemic plasmacytosis the same entity?
    Kayasut K; Le Tourneau A; Rio B; Bost-Bezeaud F; Heuberger L; Diebold J; Audouin J
    Histopathology; 2006 Nov; 49(5):557-8. PubMed ID: 17064311
    [No Abstract]   [Full Text] [Related]  

  • 38. IgA nephropathy associated with Castleman disease with cutaneous involvement.
    Komatsuda A; Wakui H; Togashi M; Sawada K
    Am J Med Sci; 2010 May; 339(5):486-90. PubMed ID: 20335784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The tumor lysis syndrome in a child with multicentric Castleman disease.
    Blanchet GV; Allen HF; Mehrotra SP; Richardson MW
    J Pediatr Hematol Oncol; 2010 Apr; 32(3):247-9. PubMed ID: 20387267
    [No Abstract]   [Full Text] [Related]  

  • 40. Castleman disease with preceding symptoms of nephrotic syndrome.
    Li Y; Tong H; Mao L; Wang H; Jin J
    Clin Nephrol; 2012 Dec; 78(6):508-10. PubMed ID: 22854167
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.